Clinical Trial Update: Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating celecoxib for cancer prevention in patients with oral leukoplakia and/or head and neck dysplasia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Leukoplakia

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED